Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration

被引：0
|
作者：
Masoud Razmara
Azita Monazzam
Britt Skogseid
机构：
[1] Uppsala University,Department of medical sciences, Science for Life Laboratory
来源：
Cell Communication and Signaling | / 16卷
关键词：
MEN1; PNET; PI3K; mTOR; Akt; Rapamycin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration
    Razmara, Masoud
    Monazzam, Azita
    Skogseid, Britt
    CELL COMMUNICATION AND SIGNALING, 2018, 16
  • [2] In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function
    Barilli, Amelia
    Visigalli, Rossana
    Sala, Roberto
    Gazzola, Gian C.
    Parolari, Alessandro
    Tremoli, Elena
    Bonomini, Sabrina
    Simon, Alexandra
    Closs, Ellen I.
    Dall'Asta, Valeria
    Bussolati, Ovidio
    CARDIOVASCULAR RESEARCH, 2008, 78 (03) : 563 - 571
  • [3] Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2)
    Lamming, Dudley W.
    Demirkan, Gokhan
    Boylan, Joan M.
    Mihaylova, Maria M.
    Peng, Tao
    Ferreira, Jonathan
    Neretti, Nicola
    Salomon, Arthur
    Sabatini, David M.
    Gruppuso, Philip A.
    FASEB JOURNAL, 2014, 28 (01): : 300 - 315
  • [4] Rapamycin (RAPA) Induces Klotho Expression through mTORC2 Activation
    Tataranni, T.
    Colucci, G.
    Biondi, G.
    Mangino, M.
    Pertosa, G.
    Simone, S.
    Ditonno, P.
    Schena, F. P.
    Gesualdo, L.
    Grandaliano, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 356 - 356
  • [5] Rapamycin Treatment of Mantle Cell Lymphoma Inhibits mTORC2 Signaling, Resulting in Increased MnSOD Expression and Hydrogen Peroxide Generation
    Briehl, Margaret M.
    Gustafson, Heather L.
    Lee, Kristy
    Tome, Margaret E.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S39 - S40
  • [6] Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
    Zeng, Zhihong
    Sarbassov, Dos D.
    Samudio, Ismael J.
    Yee, Karen W. L.
    Munsell, Mark F.
    Jackson, C. Ellen
    Giles, Francis J.
    Sabatini, David M.
    Andreeff, Michael
    Konopleva, Marina
    BLOOD, 2007, 109 (08) : 3509 - 3512
  • [7] Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation
    Walker, Natalie M.
    Belloli, Elizabeth A.
    Stuckey, Linda
    Chan, Kevin M.
    Lin, Jules
    Lynch, William
    Chang, Andrew
    Mazzoni, Serina M.
    Fingar, Diane C.
    Lama, Vibha N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (12) : 6262 - 6271
  • [8] CELL MIGRATION MTORC2 brings up the rear
    David, Rachel
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (02) : 74 - 74
  • [9] Rapamycin Regulates Akt and ERK Phosphorylation Through mTORC1 and mTORC2 Signaling Pathways
    Chen, Xian-Guo
    Liu, Fei
    Song, Xing-Fu
    Wang, Zhi-Hua
    Dong, Zi-Qiang
    Hu, Zhi-Quan
    Lan, Ru-Zhu
    Guan, Wei
    Zhou, Tian-Gui
    Xu, Xiao-Ming
    Lei, Hong
    Ye, Zhang-Qun
    Peng, E-Jun
    Du, Li-Huan
    Zhuang, Qian-Yuan
    MOLECULAR CARCINOGENESIS, 2010, 49 (06) : 603 - 610
  • [10] Rapamycin analogs reduce mTORC2 signaling and inhibit AKT activation in AML.
    Zeng, Zhihong
    Sarbassov, Dos D.
    Giles, Francis J.
    Samudio, Ismael
    Yee, Karen W. L.
    Jackson, C. Ellen
    Sabatini, David M.
    Andreeff, Michael
    Konopleva, Marina
    BLOOD, 2006, 108 (11) : 50A - 50A
12345